More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.
Read More
COVID-19 in North America
APPAM Fall Research Conference 2026
Abt is a Gold Sponsor of APPAM 2026. Catch us in Boston, in our sessions and at booth 304, or connect with the team here!
National Association of Medicaid Directors (NAMD) Fall Conference 2026
Abt Global is a Sapphire sponsor of the NAMD 2026 Fall Conference. Find our Medicaid policy and data team at Booth 122.
Beyond the Red Flag: A Smarter Approach to Medicaid Program Integrity
How explainable, human-guided AI can help Medicaid programs focus on meaningful fraud signals, reduce noise, and act earlier.
Evaluating SMART Recovery in Active-Duty Service Members
Abt is testing whether the SMART Recovery program can reduce risky drinking and support military readiness.